Share Price and Basic Stock Data
Last Updated: November 14, 2025, 8:11 am
| PEG Ratio | 3.41 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fine Organic Industries Ltd operates in the chemicals sector, focusing on organic chemicals, and has reported a market capitalization of ₹13,828 Cr. The company’s stock price stood at ₹4,510. Revenue trends reveal significant growth over the years; sales rose from ₹660 Cr in March 2016 to ₹3,023 Cr in March 2023, indicating a compounded annual growth rate (CAGR) that showcases strong market demand. However, the most recent fiscal year saw a decline to ₹2,123 Cr in March 2024, followed by a modest recovery to ₹2,269 Cr in March 2025. Quarterly sales figures also reflect volatility, with June 2023 sales of ₹547 Cr and a subsequent slight decrease to ₹540 Cr in September 2023. Overall, the company faces pressure from fluctuating revenues, yet its long-term sales trajectory remains positive, underlined by a strong customer base and product portfolio.
Profitability and Efficiency Metrics
Fine Organic Industries has maintained robust profitability metrics, with a reported net profit of ₹414 Cr, translating into a profit margin of 18.12% for March 2025. The operating profit margin (OPM) stood at 23% for the same period, showcasing effective cost management strategies. The company recorded significant improvements in its interest coverage ratio, which rose to an impressive 278.05x, indicating a strong ability to meet interest obligations. Return on equity (ROE) was recorded at 19.5%, while return on capital employed (ROCE) was 26.4%, both of which are above average for the chemicals sector. However, the cash conversion cycle increased to 110 days, suggesting potential inefficiencies in inventory and receivables management, which could affect liquidity in the short term.
Balance Sheet Strength and Financial Ratios
Fine Organic Industries boasts a solid balance sheet with total reserves increasing to ₹2,280 Cr and minimal borrowings of just ₹3 Cr as of March 2025. This results in a debt-to-equity ratio of 0.00, reflecting a conservative capital structure that minimizes financial risk. The company’s current ratio is an impressive 8.46, indicating excellent short-term liquidity, while the quick ratio of 6.76 further supports this strength. The book value per share has increased to ₹748.61, up from ₹502.69 in the previous year, enhancing shareholder value. However, the price-to-book value ratio stood at 5.34x, which is high compared to typical sector ranges, suggesting the stock may be overvalued relative to its net assets. These financial metrics illustrate a strong operational foundation, although the valuation may raise concerns among potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fine Organic Industries reflects strong promoter confidence, with promoters holding 75% of the shares. This stable ownership structure likely contributes to investor trust in the company’s long-term vision. Foreign institutional investors (FIIs) accounted for 4.80% of the ownership as of March 2025, indicating moderate foreign interest. Domestic institutional investors (DIIs) held 11.94%, while the public float was 8.26%, representing a diverse investor base. The number of shareholders has declined to 1,05,097 from a peak of 1,34,261 in June 2023, which may signal a reduction in retail investor enthusiasm. Overall, while the promoter holding provides stability, the drop in public shareholders could indicate growing concerns about stock performance or market conditions.
Outlook, Risks, and Final Insight
Fine Organic Industries faces a mixed outlook driven by its strong fundamentals but tempered by recent revenue fluctuations. Key strengths include its low debt levels and robust profitability ratios, which position it well against industry peers. However, risks such as increasing operational costs and a rising cash conversion cycle could hinder performance if not managed effectively. The company’s ability to sustain growth in a competitive chemicals market, marked by price volatility and demand fluctuations, remains crucial. Should the company enhance its operational efficiency and stabilize revenue, it could unlock significant shareholder value. Conversely, any further decline in sales or profitability could pose risks to investor confidence and market valuation, necessitating vigilant monitoring of operational and market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fine Organic Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 108 Cr. | 303 | 456/255 | 112 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,747 Cr. | 9,772 | 14,250/8,150 | 56.1 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 36.0 Cr. | 120 | 329/114 | 17.8 | 26.9 | 0.83 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 302 Cr. | 378 | 387/163 | 16.8 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,344.79 Cr | 1,640.96 | 389.55 | 332.47 | 0.38% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 748 | 919 | 760 | 597 | 547 | 540 | 488 | 547 | 550 | 596 | 517 | 607 | 588 |
| Expenses | 533 | 665 | 600 | 395 | 407 | 410 | 371 | 403 | 410 | 446 | 414 | 487 | 466 |
| Operating Profit | 214 | 254 | 159 | 202 | 140 | 130 | 117 | 144 | 139 | 150 | 103 | 120 | 123 |
| OPM % | 29% | 28% | 21% | 34% | 26% | 24% | 24% | 26% | 25% | 25% | 20% | 20% | 21% |
| Other Income | 17 | 19 | 15 | 13 | 14 | 17 | 17 | 22 | 24 | 22 | 25 | 26 | 47 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| Depreciation | 11 | 12 | 12 | 13 | 12 | 14 | 15 | 15 | 12 | 12 | 13 | 15 | 12 |
| Profit before tax | 219 | 260 | 161 | 201 | 143 | 132 | 119 | 150 | 151 | 159 | 115 | 130 | 157 |
| Tax % | 27% | 22% | 34% | 26% | 30% | 22% | 21% | 24% | 25% | 26% | 28% | 25% | 26% |
| Net Profit | 160 | 203 | 106 | 149 | 100 | 103 | 94 | 115 | 113 | 117 | 83 | 97 | 117 |
| EPS in Rs | 52.12 | 66.09 | 34.65 | 48.74 | 32.54 | 33.71 | 30.73 | 37.36 | 36.94 | 38.30 | 26.97 | 31.68 | 38.19 |
Last Updated: August 20, 2025, 2:40 pm
Below is a detailed analysis of the quarterly data for Fine Organic Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 588.00 Cr.. The value appears to be declining and may need further review. It has decreased from 607.00 Cr. (Mar 2025) to 588.00 Cr., marking a decrease of 19.00 Cr..
- For Expenses, as of Jun 2025, the value is 466.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 487.00 Cr. (Mar 2025) to 466.00 Cr., marking a decrease of 21.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 20.00% (Mar 2025) to 21.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 21.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 27.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 97.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 20.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 38.19. The value appears strong and on an upward trend. It has increased from 31.68 (Mar 2025) to 38.19, marking an increase of 6.51.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 4:16 pm
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 660 | 778 | 856 | 1,060 | 1,038 | 1,133 | 1,876 | 3,023 | 2,123 | 2,269 | 2,308 |
| Expenses | 514 | 633 | 697 | 827 | 803 | 935 | 1,513 | 2,194 | 1,591 | 1,757 | 1,813 |
| Operating Profit | 146 | 145 | 158 | 234 | 235 | 198 | 363 | 829 | 532 | 512 | 495 |
| OPM % | 22% | 19% | 19% | 22% | 23% | 17% | 19% | 27% | 25% | 23% | 21% |
| Other Income | 8 | 4 | 16 | 20 | 20 | 17 | 33 | 64 | 71 | 98 | 120 |
| Interest | 7 | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 2 |
| Depreciation | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 52 |
| Profit before tax | 117 | 121 | 151 | 234 | 216 | 162 | 352 | 841 | 544 | 555 | 561 |
| Tax % | 35% | 36% | 37% | 40% | 24% | 26% | 26% | 26% | 24% | 26% | |
| Net Profit | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 414 |
| EPS in Rs | 157.74 | 161.22 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 201.60 | 134.34 | 133.89 | 135.14 |
| Dividend Payout % | 29% | 9% | 23% | 16% | 13% | 28% | 11% | 4% | 7% | 8% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 2.63% | 21.79% | 43.16% | 21.32% | -27.27% | 116.67% | 137.69% | -33.33% | -0.49% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.16% | 21.36% | -21.83% | -48.60% | 143.94% | 21.03% | -171.03% | 32.85% |
Fine Organic Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 7% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 17% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | -7% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 28% |
| Last Year: | 19% |
Last Updated: September 4, 2025, 9:35 pm
Balance Sheet
Last Updated: November 9, 2025, 1:31 pm
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 249 | 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,462 |
| Borrowings | 102 | 40 | 54 | 128 | 125 | 89 | 59 | 29 | 4 | 3 | 16 |
| Other Liabilities | 63 | 76 | 81 | 74 | 108 | 127 | 219 | 237 | 182 | 213 | 167 |
| Total Liabilities | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,660 |
| Fixed Assets | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 | 373 |
| CWIP | 6 | 3 | 32 | 106 | 6 | 26 | 14 | 40 | 30 | 27 | 36 |
| Investments | 0 | 11 | 11 | 10 | 33 | 31 | 31 | 39 | 36 | 35 | 34 |
| Other Assets | 289 | 334 | 399 | 508 | 597 | 694 | 962 | 1,513 | 1,774 | 2,085 | 2,218 |
| Total Assets | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,660 |
Below is a detailed analysis of the balance sheet data for Fine Organic Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,462.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,280.00 Cr. (Mar 2025) to 2,462.00 Cr., marking an increase of 182.00 Cr..
- For Borrowings, as of Sep 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). It has decreased from 213.00 Cr. (Mar 2025) to 167.00 Cr., marking a decrease of 46.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,660.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,511.00 Cr. (Mar 2025) to 2,660.00 Cr., marking an increase of 149.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 373.00 Cr.. The value appears strong and on an upward trend. It has increased from 363.00 Cr. (Mar 2025) to 373.00 Cr., marking an increase of 10.00 Cr..
- For CWIP, as of Sep 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,218.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,085.00 Cr. (Mar 2025) to 2,218.00 Cr., marking an increase of 133.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,660.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,511.00 Cr. (Mar 2025) to 2,660.00 Cr., marking an increase of 149.00 Cr..
Notably, the Reserves (2,462.00 Cr.) exceed the Borrowings (16.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 44.00 | 105.00 | 104.00 | 106.00 | 110.00 | 109.00 | 304.00 | 800.00 | 528.00 | 509.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 52 | 62 | 54 | 47 | 52 | 59 | 42 | 54 | 53 |
| Inventory Days | 72 | 68 | 58 | 50 | 79 | 63 | 72 | 91 | 78 | 100 |
| Days Payable | 50 | 47 | 46 | 30 | 51 | 49 | 47 | 36 | 41 | 43 |
| Cash Conversion Cycle | 71 | 72 | 75 | 74 | 74 | 66 | 84 | 97 | 91 | 110 |
| Working Capital Days | 80 | 69 | 80 | 76 | 63 | 65 | 79 | 76 | 77 | 104 |
| ROCE % | 35% | 38% | 44% | 32% | 22% | 39% | 65% | 31% | 26% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 752,764 | 0.71 | 326.08 | 752,764 | 2025-04-22 15:57:01 | 0% |
| Axis Small Cap Fund | 713,350 | 1.58 | 309.01 | 713,350 | 2025-04-22 15:57:01 | 0% |
| SBI Small Cap Fund | 700,000 | 1.19 | 303.22 | 700,000 | 2025-04-22 14:12:25 | 0% |
| Axis Midcap Fund | 307,724 | 0.53 | 133.3 | 307,724 | 2025-04-22 15:57:01 | 0% |
| Axis Flexi Cap Fund | 304,168 | 1.15 | 131.76 | 304,168 | 2025-04-22 15:57:01 | 0% |
| Canara Robeco Small Cap Fund | 77,057 | 0.35 | 33.38 | 77,057 | 2025-04-22 15:57:01 | 0% |
| Axis Multicap Fund | 61,298 | 0.53 | 26.55 | 61,298 | 2025-04-22 15:57:01 | 0% |
| UTI Small Cap Fund | 46,684 | 0.55 | 20.22 | 46,684 | 2025-04-22 15:57:01 | 0% |
| Bandhan Flexi Cap Fund | 45,171 | 0.29 | 19.57 | 45,171 | 2025-04-22 15:57:01 | 0% |
| Axis Equity Hybrid Fund | 37,134 | 1.01 | 16.09 | 37,134 | 2025-04-22 15:57:01 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 133.89 | 134.34 | 201.60 | 84.71 | 39.25 |
| Diluted EPS (Rs.) | 133.89 | 134.34 | 201.60 | 84.71 | 39.25 |
| Cash EPS (Rs.) | 151.21 | 153.52 | 217.80 | 98.06 | 54.93 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 748.61 | 626.57 | 502.69 | 312.85 | 238.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 748.61 | 626.57 | 502.69 | 312.85 | 238.57 |
| Revenue From Operations / Share (Rs.) | 740.10 | 692.42 | 986.00 | 611.96 | 369.61 |
| PBDIT / Share (Rs.) | 199.11 | 197.62 | 291.99 | 129.67 | 70.56 |
| PBIT / Share (Rs.) | 182.06 | 179.31 | 276.37 | 116.66 | 55.31 |
| PBT / Share (Rs.) | 181.34 | 178.33 | 274.88 | 114.99 | 53.31 |
| Net Profit / Share (Rs.) | 134.16 | 135.20 | 202.18 | 85.04 | 39.68 |
| NP After MI And SOA / Share (Rs.) | 133.89 | 134.34 | 201.60 | 84.67 | 39.24 |
| PBDIT Margin (%) | 26.90 | 28.54 | 29.61 | 21.18 | 19.09 |
| PBIT Margin (%) | 24.59 | 25.89 | 28.02 | 19.06 | 14.96 |
| PBT Margin (%) | 24.50 | 25.75 | 27.87 | 18.79 | 14.42 |
| Net Profit Margin (%) | 18.12 | 19.52 | 20.50 | 13.89 | 10.73 |
| NP After MI And SOA Margin (%) | 18.09 | 19.40 | 20.44 | 13.83 | 10.61 |
| Return on Networth / Equity (%) | 17.88 | 21.44 | 40.10 | 27.06 | 16.45 |
| Return on Capital Employeed (%) | 24.30 | 28.58 | 54.94 | 36.30 | 21.39 |
| Return On Assets (%) | 16.35 | 19.54 | 34.21 | 20.99 | 12.70 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.06 | 0.07 |
| Asset Turnover Ratio (%) | 0.98 | 1.08 | 2.01 | 1.71 | 1.24 |
| Current Ratio (X) | 8.46 | 9.13 | 5.37 | 3.53 | 4.01 |
| Quick Ratio (X) | 6.76 | 7.71 | 3.68 | 2.60 | 3.20 |
| Inventory Turnover Ratio (X) | 7.28 | 3.07 | 7.20 | 7.44 | 5.95 |
| Dividend Payout Ratio (NP) (%) | 7.46 | 6.69 | 4.46 | 12.99 | 7.64 |
| Dividend Payout Ratio (CP) (%) | 6.62 | 5.89 | 4.14 | 11.26 | 5.50 |
| Earning Retention Ratio (%) | 92.54 | 93.31 | 95.54 | 87.01 | 92.36 |
| Cash Earning Retention Ratio (%) | 93.38 | 94.11 | 95.86 | 88.74 | 94.50 |
| Interest Coverage Ratio (X) | 278.05 | 249.04 | 195.73 | 77.82 | 35.30 |
| Interest Coverage Ratio (Post Tax) (X) | 188.34 | 171.61 | 136.52 | 52.03 | 20.84 |
| Enterprise Value (Cr.) | 11296.88 | 11309.92 | 12708.88 | 12135.04 | 6792.44 |
| EV / Net Operating Revenue (X) | 4.98 | 5.33 | 4.20 | 6.47 | 5.99 |
| EV / EBITDA (X) | 18.50 | 18.67 | 14.20 | 30.52 | 31.40 |
| MarketCap / Net Operating Revenue (X) | 5.40 | 5.82 | 4.37 | 6.56 | 6.18 |
| Retention Ratios (%) | 92.53 | 93.30 | 95.53 | 87.00 | 92.35 |
| Price / BV (X) | 5.34 | 6.43 | 8.57 | 12.83 | 9.57 |
| Price / Net Operating Revenue (X) | 5.40 | 5.82 | 4.37 | 6.56 | 6.18 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.02 | 0.01 |
After reviewing the key financial ratios for Fine Organic Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For Cash EPS (Rs.), as of Mar 25, the value is 151.21. This value is within the healthy range. It has decreased from 153.52 (Mar 24) to 151.21, marking a decrease of 2.31.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 740.10. It has increased from 692.42 (Mar 24) to 740.10, marking an increase of 47.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 199.11. This value is within the healthy range. It has increased from 197.62 (Mar 24) to 199.11, marking an increase of 1.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 182.06. This value is within the healthy range. It has increased from 179.31 (Mar 24) to 182.06, marking an increase of 2.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 181.34. This value is within the healthy range. It has increased from 178.33 (Mar 24) to 181.34, marking an increase of 3.01.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 134.16. This value is within the healthy range. It has decreased from 135.20 (Mar 24) to 134.16, marking a decrease of 1.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For PBDIT Margin (%), as of Mar 25, the value is 26.90. This value is within the healthy range. It has decreased from 28.54 (Mar 24) to 26.90, marking a decrease of 1.64.
- For PBIT Margin (%), as of Mar 25, the value is 24.59. This value exceeds the healthy maximum of 20. It has decreased from 25.89 (Mar 24) to 24.59, marking a decrease of 1.30.
- For PBT Margin (%), as of Mar 25, the value is 24.50. This value is within the healthy range. It has decreased from 25.75 (Mar 24) to 24.50, marking a decrease of 1.25.
- For Net Profit Margin (%), as of Mar 25, the value is 18.12. This value exceeds the healthy maximum of 10. It has decreased from 19.52 (Mar 24) to 18.12, marking a decrease of 1.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.09. This value is within the healthy range. It has decreased from 19.40 (Mar 24) to 18.09, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 21.44 (Mar 24) to 17.88, marking a decrease of 3.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.30. This value is within the healthy range. It has decreased from 28.58 (Mar 24) to 24.30, marking a decrease of 4.28.
- For Return On Assets (%), as of Mar 25, the value is 16.35. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 16.35, marking a decrease of 3.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.08 (Mar 24) to 0.98, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 8.46. This value exceeds the healthy maximum of 3. It has decreased from 9.13 (Mar 24) to 8.46, marking a decrease of 0.67.
- For Quick Ratio (X), as of Mar 25, the value is 6.76. This value exceeds the healthy maximum of 2. It has decreased from 7.71 (Mar 24) to 6.76, marking a decrease of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.28. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 7.28, marking an increase of 4.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.46. This value is below the healthy minimum of 20. It has increased from 6.69 (Mar 24) to 7.46, marking an increase of 0.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.62. This value is below the healthy minimum of 20. It has increased from 5.89 (Mar 24) to 6.62, marking an increase of 0.73.
- For Earning Retention Ratio (%), as of Mar 25, the value is 92.54. This value exceeds the healthy maximum of 70. It has decreased from 93.31 (Mar 24) to 92.54, marking a decrease of 0.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.38. This value exceeds the healthy maximum of 70. It has decreased from 94.11 (Mar 24) to 93.38, marking a decrease of 0.73.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 278.05. This value is within the healthy range. It has increased from 249.04 (Mar 24) to 278.05, marking an increase of 29.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 188.34. This value is within the healthy range. It has increased from 171.61 (Mar 24) to 188.34, marking an increase of 16.73.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,296.88. It has decreased from 11,309.92 (Mar 24) to 11,296.88, marking a decrease of 13.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.98. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 4.98, marking a decrease of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 18.50. This value exceeds the healthy maximum of 15. It has decreased from 18.67 (Mar 24) to 18.50, marking a decrease of 0.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
- For Retention Ratios (%), as of Mar 25, the value is 92.53. This value exceeds the healthy maximum of 70. It has decreased from 93.30 (Mar 24) to 92.53, marking a decrease of 0.77.
- For Price / BV (X), as of Mar 25, the value is 5.34. This value exceeds the healthy maximum of 3. It has decreased from 6.43 (Mar 24) to 5.34, marking a decrease of 1.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fine Organic Industries Ltd:
- Net Profit Margin: 18.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.3% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.88% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 188.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 33.4 (Industry average Stock P/E: 389.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Fine House, Anandji Street, Mumbai Maharashtra 400077 | investors@fineorganics.com http://www.fineorganics.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukesh Shah | Chairman & Wholetime Director |
| Mr. Jayen Shah | Managing Director |
| Mr. Tushar Shah | WholeTime Director & CEO |
| Mr. Bimal Shah | Executive Director |
| Mr. Nikhil Kamat | Executive Director |
| Mr. Kaushik Shah | Independent Director |
| Mr. Mahesh Sarda | Independent Director |
| Mr. Thiruvengadam Parthasarathi | Independent Director |
| Ms. Pratima Umarji | Independent Director |
| Mr. Prakash Apte | Independent Director |
| Ms. Rashi Mehta | Independent Director |
FAQ
What is the intrinsic value of Fine Organic Industries Ltd?
Fine Organic Industries Ltd's intrinsic value (as of 14 November 2025) is 4220.53 which is 3.35% lower the current market price of 4,367.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 13,390 Cr. market cap, FY2025-2026 high/low of 5,494/3,355, reserves of ₹2,462 Cr, and liabilities of 2,660 Cr.
What is the Market Cap of Fine Organic Industries Ltd?
The Market Cap of Fine Organic Industries Ltd is 13,390 Cr..
What is the current Stock Price of Fine Organic Industries Ltd as on 14 November 2025?
The current stock price of Fine Organic Industries Ltd as on 14 November 2025 is 4,367.
What is the High / Low of Fine Organic Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fine Organic Industries Ltd stocks is 5,494/3,355.
What is the Stock P/E of Fine Organic Industries Ltd?
The Stock P/E of Fine Organic Industries Ltd is 33.4.
What is the Book Value of Fine Organic Industries Ltd?
The Book Value of Fine Organic Industries Ltd is 808.
What is the Dividend Yield of Fine Organic Industries Ltd?
The Dividend Yield of Fine Organic Industries Ltd is 0.25 %.
What is the ROCE of Fine Organic Industries Ltd?
The ROCE of Fine Organic Industries Ltd is 26.4 %.
What is the ROE of Fine Organic Industries Ltd?
The ROE of Fine Organic Industries Ltd is 19.5 %.
What is the Face Value of Fine Organic Industries Ltd?
The Face Value of Fine Organic Industries Ltd is 5.00.